Evaluation of the risk of pathologic fractures secondary to metastatic bone disease

Orthopedics

Volumn 24, Issue 6, 2001, Pages 612-617

  Patel, B ^a   DeGroot III, H ^a  

^a University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

ACCURACY; BIOMECHANICS; BONE DEVELOPMENT; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER PAIN; CANCER RADIOTHERAPY; CONTROLLED STUDY; HUMAN; KIDNEY CARCINOMA; LUNG CANCER; MEASUREMENT; ORCHIECTOMY; OSTEOLYSIS; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; THYROID CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

BIOMECHANICS; BONE NEOPLASMS; BREAST NEOPLASMS; FEMORAL FRACTURES; FRACTURES, STRESS; HUMANS; RISK ASSESSMENT;

EID: 0034954903     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. The natural history and management of mammary cancer metastatic to the femur
2. Prophylactic internal fixation of the femur in metastatic breast cancer
3. Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures
4. The treatment of pathologic and impending pathologic fractures of the proximal femur in the elderly
5. Skeletal metastases
6. Management of pathologic fractures
7. Incidence, prevalence and distribution of bone metastases
8. Skeletal complications of malignancy
9. Predicting pathologic fracture risk in the management of metastatic bone defects
10. Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma
11. Survival times after treatment of pathologic fractures
12. Fracture healing in metastatic bone disease
13. Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma
14. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma
15. Treatment of osseous metastases secondary to renal cell carcinoma
16. Radical surgery for the solitary bony metastasis from renal-cell carcinoma
17. Pathologic fracture risk in rehabilitation of patients with bony metastases
18. Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures
19. New trends in the management of lower extremity metastases
20. The palliation of symptomatic osseous metastases: Final results of the Study by the Radiation Therapy Oncology Group
21. Metastatic breast cancer in the femur: A search for the lesion at risk of fracture
22. Impending pathologic fractures from metastatic malignancy: Evaluation and management
23. Nonoperative management of femoral, humeral, and acetabular metastases in patients with breast carcinoma
24. The management of cancer metastatic to bone
25. Bone metastases: Pathogenesis, treatment, and rationale for use of resorption inhibitors
26. Prophylactic internal fixation of secondary neoplastic deposits in long bones
27. Incidence of fracture through metastases in long bones
28. Surgical management of secondary neoplastic fractures
29. Orthopedic management of patients with metastatic carcinoma of the breast
30. Femoral metastases and fractures from breast cancer
31. Surgical treatment for secondary neoplastic fractures. A retrospective study of 96 patients
32. Intramedullary fixation of pathological fractures and lesions of the subtrochanteric region of the femur
33. The biomechanics of torsional fractures: The stress concentration effect of a drill hole
34. Biomechanics of pathologic fractures
35. Structural consequences of transcortical holes in long bones loaded in torsion
36. Structural consequences of endosteal metastatic lesions in long bones
37. The role of surgery in the management of pathologic fractures
38. Metastasis to bone from carcinoma of the breast
39. Radiation treatment of metastatic bone disease
40. Mechanical properties of trabecular bone within and adjacent to osseous metastases